Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Hepatology. 2016 May 28;64(4):1163–1177. doi: 10.1002/hep.28602
Treatment DEN/CCl4 DEN/TCPOBOP
Cre Driver AAV-TBG-Cre Foxl1-Cre AAV-TBG-Cre Foxl1-Cre
Labeled cells Hepatocytes HPCs Hepatocytes HPCs
Number of mice 9 9 11 9
Number of HCAs analyzed 27 6 7 17
Number of YFP+ HCAs 26 0 7 0
Number of HCCs analyzed 3 0 1 8
Number of YFP+ HCCs 3 0 1 0
Number of HCCs with Sox9+ tumor-associated duct structures 3 0 0 8
Number of HCCs with Sox9+ parenchymal cells 3 0 1 6
Number of OPN+ HCCs 3 0 1 8
Number of Yap1+ HCCs 3 0 1 8
Number of HCCs with EpCAM+ tumor-associated duct structures 3 0 0 7
Number of HCCs with EpCAM+ parenchymal cells 0 0 1 4
Number of CK19+ HCC nodules 0 0 0 7
Number of HCCs with nuclear β-catenin-positive parenchymal cells 0 0 1 7
Number of Afp+ HCC nodules 3 0 1 8